Performance of serum-based biomarkers in fibrosis prediction of chronic hepatitis B patients in real life practice.
Minerva gastroenterology（2023）
摘要
FIB4 has a moderate performance and may have a valuable role in excluding significant fibrosis in CHB patients in daily practice.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要